NEK11 involved in cancer development – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

BRIC > Research Stories > NEK11

04 November 2009

NEK11 involved in cancer development

Researchers from BRIC and the European Institute of Oncology in Italy have demonstrated that NEK11 is an important component of the pathway enforcing the G2/M checkpoint, suggesting that genetic mutations in NEK11 may contribute to the development of human cancer. Read more...